Pre-eclampsia rates in the United States, 1980-2010: age-period-cohort analysis, BMJ, vol.347, issue.nov07 15, p.6564, 2013. ,
DOI : 10.1136/bmj.f6564
Preeclampsia: A renal perspective, Kidney International, vol.67, issue.6, pp.2101-2113, 2005. ,
DOI : 10.1111/j.1523-1755.2005.00316.x
URL : http://doi.org/10.1111/j.1523-1755.2005.00316.x
Diagnosis and management of hemolysis, elevated liver enzymes, and low platelets syndrome, Clinics in Perinatology, vol.31, issue.4, pp.807-833, 2004. ,
DOI : 10.1016/j.clp.2004.06.008
Maternal morbidity and mortality in 442 pregnancies with hemolysis, elevated liver enzymes, and low platelets (HELLP syndrome), American Journal of Obstetrics and Gynecology, vol.169, issue.4, pp.1000-1006, 1993. ,
DOI : 10.1016/0002-9378(93)90043-I
Are clinical symptoms more predictive than laboratory parameters for adverse maternal outcome in HELLP syndrome?, Acta Obstetricia et Gynecologica Scandinavica, vol.86, issue.6, pp.648-651, 2007. ,
DOI : 10.1080/00016340601185384
Diagnosis, Controversies, and Management of the Syndrome of Hemolysis, Elevated Liver Enzymes, and Low Platelet Count, Obstetrics & Gynecology, vol.103, issue.5, Part 1, pp.981-991, 2004. ,
DOI : 10.1097/01.AOG.0000126245.35811.2a
OUTCOME OF PREGNANCIES WITH HELLP SYNDROME COMPLICATED BY ACUTE RENAL FAILURE (1989???1999), Renal Failure, vol.280, issue.6, pp.319-327, 1989. ,
DOI : 10.1001/jama.280.6.559
Pathogenesis of acute renal failure associated with the HELLP syndrome: a case report and review of the literature, European Journal of Obstetrics & Gynecology and Reproductive Biology, vol.108, issue.1, pp.99-102, 2003. ,
DOI : 10.1016/S0301-2115(02)00352-4
A Fetal Fatty-Acid Oxidation Disorder as a Cause of Liver Disease in Pregnant Women, New England Journal of Medicine, vol.340, issue.22, pp.1723-1731, 1999. ,
DOI : 10.1056/NEJM199906033402204
Liver Disease in Pregnancy, New England Journal of Medicine, vol.335, issue.8, pp.569-576, 1996. ,
DOI : 10.1056/NEJM199608223350807
Genetics and Outcome of Atypical Hemolytic Uremic Syndrome: A Nationwide French Series Comparing Children and Adults, Clinical Journal of the American Society of Nephrology, vol.8, issue.4, pp.554-562, 2013. ,
DOI : 10.2215/CJN.04760512
Pregnancy-Associated Hemolytic Uremic Syndrome Revisited in the Era of Complement Gene Mutations, Journal of the American Society of Nephrology, vol.21, issue.5, pp.859-867, 2010. ,
DOI : 10.1681/ASN.2009070706
URL : https://hal.archives-ouvertes.fr/hal-00512540
Unexpected frequency of Upshaw-Schulman syndrome in pregnancy-onset thrombotic thrombocytopenic purpura, Blood, vol.119, issue.24, pp.5888-5897, 2012. ,
DOI : 10.1182/blood-2012-02-408914
Thrombotic thrombocytopenic purpura in 166 pregnancies: 1955-2006, American Journal of Obstetrics and Gynecology, vol.199, issue.2, pp.98-104, 2008. ,
DOI : 10.1016/j.ajog.2008.03.011
Thrombotic thrombocytopenic purpura and pregnancy: presentation, management, and subsequent pregnancy outcomes, Blood, vol.124, issue.2, pp.211-219, 2014. ,
DOI : 10.1182/blood-2014-02-553131
URL : http://www.bloodjournal.org/content/bloodjournal/124/2/211.full.pdf
Survival and relapse in patients with thrombotic thrombocytopenic purpura, Blood, vol.115, issue.8, pp.1500-1511, 2010. ,
DOI : 10.1182/blood-2009-09-243790
URL : http://www.bloodjournal.org/content/bloodjournal/115/8/1500.full.pdf
Cardiac troponin-I on diagnosis predicts early death and refractoriness in acquired thrombotic thrombocytopenic purpura. Experience of the French Thrombotic Microangiopathies Reference Center, Journal of Thrombosis and Haemostasis, vol.7, issue.2, pp.293-302, 2015. ,
DOI : 10.1371/journal.pone.0038573
URL : http://onlinelibrary.wiley.com/doi/10.1111/jth.12790/pdf
Catastrophic antiphospholipid syndrome and pregnancy: an experience of 13 cases, Rheumatology, vol.52, issue.9, pp.1635-1641, 2013. ,
DOI : 10.1093/rheumatology/ket167
Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia, Journal of Clinical Investigation, vol.111, issue.5, pp.649-658, 2003. ,
DOI : 10.1172/JCI17189
URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC151901/pdf
Soluble endoglin contributes to the pathogenesis of preeclampsia, Nature Medicine, vol.274, issue.6, pp.642-649, 2006. ,
DOI : 10.1161/01.ATV.10.4.653
Soluble endoglin in preeclamptic patients with or without HELLP syndrome, American Journal of Obstetrics and Gynecology, vol.202, issue.6, pp.594-591, 2010. ,
DOI : 10.1016/j.ajog.2010.03.006
Dynamics of complement activation in aHUS and how to monitor eculizumab therapy, Blood, vol.124, issue.11, pp.1715-1726, 2014. ,
DOI : 10.1182/blood-2014-02-558296
Factor H, membrane cofactor protein, and factor I mutations in patients with hemolysis, elevated liver enzymes, and low platelet count syndrome, Blood, vol.112, issue.12, pp.4542-4545, 2008. ,
DOI : 10.1182/blood-2008-03-144691
The genetics of the alternative pathway of complement in the pathogenesis of HELLP syndrome, The Journal of Maternal-Fetal & Neonatal Medicine, vol.26, issue.11, pp.2322-2325, 2012. ,
DOI : 10.1159/000078679
Purpura thrombotique thrombocytop??nique acquis idiopathique, La Presse M??dicale, vol.35, issue.12, pp.1876-1886, 2006. ,
DOI : 10.1016/S0755-4982(06)74920-X
Prognostic value of inhibitory anti-ADAMTS13 antibodies in adult-acquired thrombotic thrombocytopenic purpura, British Journal of Haematology, vol.138, issue.1, pp.66-74, 2006. ,
DOI : 10.1182/blood-2003-11-4035
URL : https://hal.archives-ouvertes.fr/hal-00453285
Unexpected frequency of Upshaw-Schulman syndrome in pregnancy-onset thrombotic thrombocytopenic purpura, Blood, vol.119, issue.24, pp.5888-5897 ,
DOI : 10.1182/blood-2012-02-408914
Specific von Willebrand factor-cleaving protease in thrombotic microangiopathies: a study of 111 cases, Blood, vol.98, issue.6, pp.1765-1772, 2001. ,
DOI : 10.1182/blood.V98.6.1765
Changes in health and disease of the metalloprotease that cleaves von Willebrand factor, Blood, vol.98, issue.9, pp.2730-2735, 2001. ,
DOI : 10.1182/blood.V98.9.2730
Correspondence. Low activity of von Willebrand factor-cleaving protease is not restricted to patients suffering from thrombotic thrombocytopenic purpura, British Journal of Haematology, vol.93, issue.4, pp.1087-1088, 2001. ,
DOI : 10.1056/NEJM199811263392203
Mild to moderate reduction of a von Willebrand factor cleaving protease (ADAMTS-13) in pregnant women with HELLP microangiopathic syndrome, Haematologica, vol.88, pp.1029-1034, 2003. ,
Thrombotic microangiopathy in pregnancy, Thrombosis Research, vol.123, issue.2, pp.56-62, 2009. ,
DOI : 10.1016/S0049-3848(09)70012-X
Obstetric Nephrology: AKI and Thrombotic Microangiopathies in Pregnancy, Clinical Journal of the American Society of Nephrology, vol.7, issue.12, pp.2100-2106, 2012. ,
DOI : 10.2215/CJN.13121211
Syndromes of thrombotic microangiopathy associated with pregnancy, Hematology, vol.2015, issue.1, pp.644-648, 2015. ,
DOI : 10.1182/asheducation-2015.1.644
Spontaneous resolution of pre-eclampsia-related thrombocytopenia, BJOG: An International Journal of Obstetrics and Gynaecology, vol.142, issue.11, pp.887-890, 1992. ,
DOI : 10.1016/0002-9378(90)90376-I
Survival and relapse in patients with thrombotic thrombocytopenic purpura, Blood, vol.115, issue.8, pp.1500-1511, 2010. ,
DOI : 10.1182/blood-2009-09-243790
URL : http://www.bloodjournal.org/content/bloodjournal/115/8/1500.full.pdf
Neurological involvement in a child with atypical hemolytic uremic syndrome, Pediatric Nephrology, vol.3, issue.12, pp.2539-2542, 2010. ,
DOI : 10.1007/s00247-004-1289-2
Renal Cortical Necrosis in Postpartum Hemorrhage: A Case Series, American Journal of Kidney Diseases, vol.68, issue.1, pp.50-57, 2016. ,
DOI : 10.1053/j.ajkd.2015.11.022
Eculizumab (Alexion), Curr Opin Investig Drugs, vol.3, pp.1017-1023, 2002. ,
Comparison of Plasma Exchange with Plasma Infusion in the Treatment of Thrombotic Thrombocytopenic Purpura, New England Journal of Medicine, vol.325, issue.6, pp.393-397, 1991. ,
DOI : 10.1056/NEJM199108083250604
Twice-daily plasma exchange for patients with refractory thrombotic thrombocytopenic purpura: the experience of the Oklahoma Registry, Transfusion, vol.48, pp.349-357, 1989. ,
Thrombotic thrombocytopenic purpura and pregnancy: presentation, management, and subsequent pregnancy outcomes, Blood, vol.124, issue.2, pp.211-219, 2014. ,
DOI : 10.1182/blood-2014-02-553131
URL : http://www.bloodjournal.org/content/bloodjournal/124/2/211.full.pdf
How we manage thrombotic microangiopathies in pregnancy, British Journal of Haematology, vol.8, issue.9, pp.821-830, 2016. ,
DOI : 10.1136/bmj.322.7294.1089
High versus standard dose methylprednisolone in the acute phase of idiopathic thrombotic thrombocytopenic purpura: a randomized study, Annals of Hematology, vol.93, issue.6, pp.591-596, 2010. ,
DOI : 10.1007/s00277-009-0877-5
URL : https://hal.archives-ouvertes.fr/hal-00494349
Efficiency of curative and prophylactic treatment with rituximab in ADAMTS13-deficient thrombotic thrombocytopenic purpura: a study of 11 cases, Blood, vol.106, issue.6, pp.1932-1937, 2005. ,
DOI : 10.1182/blood-2005-03-0848
Efficacy and safety of first-line rituximab in severe, acquired thrombotic thrombocytopenic purpura with a suboptimal response to plasma exchange. Experience of the French Thrombotic Microangiopathies Reference Center, Critical Care Medicine, vol.40, issue.1, pp.104-111, 2012. ,
DOI : 10.1097/CCM.0b013e31822e9d66
Efficacy of rituximab and concurrent plasma exchange in the treatment of thrombotic thrombocytopenic purpura, Clin Adv Hematol Oncol, vol.4, pp.210-214, 2006. ,
More about low-dose rituximab and plasma exchange as front-line therapy for patients with thrombotic thrombocytopenic purpura, Hematology, vol.21, issue.5, pp.311-316, 2016. ,
DOI : 10.1182/blood-2014-10-559211
Rituximab reduces risk for relapse in patients with thrombotic thrombocytopenic purpura, Blood, vol.127, issue.24, pp.3092-3094, 2016. ,
DOI : 10.1182/blood-2016-03-703827
Biologic therapies and pregnancy: the story so far, Rheumatology, vol.53, issue.8, pp.1377-1385, 2014. ,
DOI : 10.1093/rheumatology/ket409
Acquired thrombotic thrombocytopenic purpura: new therapeutic options and their optimal use, Journal of Thrombosis and Haemostasis, vol.119, issue.1, pp.223-229, 2015. ,
DOI : 10.1182/blood-2011-12-399501
URL : http://onlinelibrary.wiley.com/doi/10.1111/jth.12934/pdf
A dose ranging phase I/II trial of the von Willebrand factor inhibiting aptamer ARC1779 in patients with congenital thrombotic thrombocytopenic purpura, Thrombosis and Haemostasis, vol.106, issue.3, pp.539-547, 2011. ,
DOI : 10.1160/TH11-02-0069
Initial experience from a double-blind, placebo-controlled, clinical outcome study of ARC1779 in patients with thrombotic thrombocytopenic purpura, American Journal of Hematology, vol.87, issue.4, 2012. ,
DOI : 10.1002/ajh.23106
Caplacizumab for Acquired Thrombotic Thrombocytopenic Purpura, New England Journal of Medicine, vol.374, issue.6, pp.511-522, 2016. ,
DOI : 10.1056/NEJMoa1505533
URL : http://boris.unibe.ch/79315/1/JKH_M.Mansouri_16021105_Caplacizumab%20for%20Acquired%20Thrombotic%20Thrombocytopenic.pdf
Thrombotic thrombocytopenic purpura, Nature Reviews Disease Primers, vol.93, p.17020, 2017. ,
DOI : 10.1182/blood-2009-12-258780
Bortezomib therapy in patients with relapsed/refractory acquired thrombotic thrombocytopenic purpura, Annals of Hematology, vol.30, issue.24, pp.1751-1756, 2016. ,
DOI : 10.1200/JCO.2011.39.6820
The role of N-acetylcysteine in the treatment of thrombotic thrombocytopenic purpura, Journal of Thrombosis and Thrombolysis, vol.54, issue.25, pp.678-683, 2016. ,
DOI : 10.3109/00365519409088566
Eculizumab in pregnancy-associated atypical hemolytic uremic syndrome: insights for optimizing management, Journal of Nephrology, vol.64, issue.159, pp.641-645, 2015. ,
DOI : 10.1053/j.ajkd.2014.01.434
Discontinuation of Eculizumab Maintenance Treatment for Atypical Hemolytic Uremic Syndrome: A Report of 10 Cases, American Journal of Kidney Diseases, vol.64, issue.4, pp.633-637, 2014. ,
DOI : 10.1053/j.ajkd.2014.01.434